A randomized, double-blinded, placebo-controlled trial of uninterrupted transdermal nitrate
therapy in 140 peri- or postmenopausal women who have frequent hot flashes. Women will be
randomly assigned to uninterrupted use of transdermal nitrate therapy (participant directed
dose-escalation of 0.2 to 0.6 mg/hr) or identical-appearing placebo patches for 12 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Alison Huang, MD University of California, San Francisco